DDReg pharma

DELIVER BETTER DATA TO ENSURE FASTER APPROVAL
DDReg Pharma
Talk To Us

Author name: development

Regulatory Compliance Pathway in the Middle East

Insights into the Pharmaceutical Regulatory Framework of the Middle East

Insights, Regulatory /

Middle Eastern pharmaceutical companies are increasingly prioritizing innovation, amid significant regulatory reforms and harmonization efforts. The region encompassing a diverse range of countries, presents both challenges and opportunities for companies aiming to enter these markets. In this Blog, we explore the key elements of the evolving regulatory frameworks in middle east. Fragmented and complex regulatory […]

Insights into the Pharmaceutical Regulatory Framework of the Middle East Read More »

challenges and Opportunities in Veterinary Regulations

Navigating Challenges and Future Opportunities in Veterinary Regulations

Blogs, Regulatory /

The field of veterinary medicine is rapidly advancing, driven by new therapies and technologies as well as increasing public health concerns about antimicrobial resistance (AMR). Regulatory agencies around the world–such as FDA, EMA and regional bodies–are adapting quickly to these changes, with regulatory frameworks constantly adapting to ensure veterinary medicinal products (VMPs) meet stringent safety

Navigating Challenges and Future Opportunities in Veterinary Regulations Read More »

Malaysia Pharmaceutical Regulatory Pathway

Understanding the Pharmaceutical Regulatory Landscape of Malaysia

Blogs, Regulatory /

Malaysia’s pharmaceutical industry is a rapidly growing sector, driven by increasing healthcare demands, advancements in medical research, and government support. For pharmaceutical companies looking to enter the Malaysian market, understanding the regulatory framework is crucial. The National Pharmaceutical Regulatory Agency (NPRA) plays a key role in overseeing drug approvals, quality standards, and compliance with national

Understanding the Pharmaceutical Regulatory Landscape of Malaysia Read More »

Registered Products in USA through Pharma Regulatory Consultant

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA

Blogs, Regulatory /

The pharmaceutical regulatory consultants are specialists in FDA regulations and can guide companies through the registration process for their products making sure that all the required documentation, clinical data, and measures to ensure compliance are in the correct order. Over the decades, the regulatory framework in the United States has advanced and driven by scientific

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA Read More »

biosimilar Submission case study

Accelerating Biosimilar Submissions Across 19 Emerging and ROW Markets

Case Studies, Regulatory /

Customer Requirement: A biopharmaceutical company aimed to submit 19 biosimilar applications across various emerging and Rest of the World (ROW) markets within a short timeframe. The company required a regulatory strategy that addressed potential gaps, identified the most efficient submission pathways, and aligned with diverse regulatory expectations to ensure successful and timely approvals. Problem Statement

Accelerating Biosimilar Submissions Across 19 Emerging and ROW Markets Read More »

PRIME vs. EU pathways: Strategy, global impact, and drug development insights

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact

Blogs, Regulatory /

In the European Union (EU), the European Medicines Agency (EMA) has implemented several expedited regulatory pathways, notably the PRIority MEdicines (PRIME) scheme, to facilitate the development and approval of promising medicines. Launched in March 2016, the PRIME scheme aims to enhance support for the development of medicines that target an unmet medical need. In addition

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact Read More »

impact of vitro diagnostic medical device regulation in EU

Understanding the Impact of IVDR on Precision Medicine Development in the EU

Blogs, Regulatory /

The European Union introduced the In Vitro Diagnostic Regulation (IVDR), an elaborate regulatory framework intended to increase safety, performance and reliability of in vitro diagnostic (IVD) medical devices. Replacing its predecessor (IVDD), EU IVDR requires stricter requirements for compliance while placing greater emphasis on clinical evidence, risk classification and post market surveillance. Precision medicine, an innovative

Understanding the Impact of IVDR on Precision Medicine Development in the EU Read More »

Current Trends patient engagement in healthcare

Patient Engagement in Healthcare: Current Trends and Future Opportunities

Blogs, Clinical Regulatory, Medical Writing, Pharmacovigilance, Regulatory /

For years, the focus of healthcare development and delivery has been on treatment and outcomes, often with limited input from patients. However, there is now a growing recognition that patients should not just be passive recipients of care—they should be active participants in their own healthcare journey. This patient-centered approach is transforming the way drugs

Patient Engagement in Healthcare: Current Trends and Future Opportunities Read More »

Collaborating for Global Success in Advanced Therapy Medicinal Products (ATMPs)

Blogs, Regulatory, Uncategorized /

Advanced Therapy Medicinal Products (ATMPs) are transforming the medical landscape, offering revolutionary treatments for diseases that previously lacked effective solutions. These products include cutting-edge innovations such as gene therapies, somatic cell therapies, and tissue-engineered products. Despite their potential, ATMPs face numerous challenges—scientific, regulatory, logistical, and financial—that hinder their development and global market access. Addressing these

Collaborating for Global Success in Advanced Therapy Medicinal Products (ATMPs) Read More »

personalized drug in development

Navigating the Challenges of Personalized Medicine in Development

Blogs, Clinical Regulatory, Pharmacovigilance, Regulatory /

The landscape of modern medicine is undergoing a revolutionary transformation, with personalized medicine at the forefront. As we move away from the “one-size-fits-all” approach and embrace treatments tailored to individual genetic profiles, lifestyle, and environmental factors, the potential to improve patient outcomes has never been greater. However, this evolution also comes with unique challenges, particularly

Navigating the Challenges of Personalized Medicine in Development Read More »